(Q24800647)

English

Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis

scientific article

In more languages

Statements

scholarly article

0 references

Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis (English)

0 references

phase I clinical trial

0 references

0 references

phase II clinical trial

0 references

0 references

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

author name string

L Moreland

1

0 references

R Gugliotti

2

0 references

K King

3

0 references

W Chase

4

0 references

M Weisman

5

0 references

T Greco

6

0 references

R Fife

7

0 references

J Korn

8

0 references

R Simms

9

0 references

J Tesser

10

0 references

J Hillson

11

0 references

J Caldwell

12

0 references

T Schnitzer

13

0 references

D Lyons

14

0 references

U Schwertschlag

15

0 references

language of work or name

0 references

publication date

2001

0 references

Arthritis Research and Therapy

0 references

3

0 references

4

0 references

247-52

0 references

Disease severity in rheumatoid arthritis: relationships of plasma tumor necrosis factor-alpha, soluble interleukin 2-receptor, soluble CD4/CD8 ratio, neopterin, and fibrin D-dimer to traditional severity and functional measures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34114

7 April 2017

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34114

7 April 2017

Epidemiology of rheumatoid arthritis: update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34114

28 September 2017

Biologic agents for treating rheumatoid arthritis. Concepts and progress

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34114

28 September 2017

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34114

30 May 2018

Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34114

30 May 2018

Interleukin-11 inhibits macrophage interleukin-12 production

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34114

30 May 2018

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=34114

28 November 2018

Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/11438043

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Slow acting drugs--outcome no different than 15 years ago

1 reference

https://pubmed.ncbi.nlm.nih.gov/11438043

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of the major fibroblast growth factors released spontaneously in inflammatory arthritis as platelet derived growth factor and tumour necrosis factor-alpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/11438043

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11438043

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production

1 reference

https://pubmed.ncbi.nlm.nih.gov/11438043

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappaB

1 reference

https://pubmed.ncbi.nlm.nih.gov/11438043

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An anti-inflammatory role for interleukin-11 in established murine collagen-induced arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11438043

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

0 references

Dimensions Publication ID

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24800647&oldid=2175259454"